DrugBiological
KXV01 clinical trials
- studies test it
- 5
- open now
- 5
- in phase 3
- 0
- first study started
- 2025
Keep track of what changes. Save the KXV01 studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Studies by the year they started
5 studies that test it; most in 2025 (4)
| Year | Studies |
|---|---|
| 2025 | 4 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 5
- Phase 2
- 1
Who runs them
Industry 3 · Other 2
TCRx Therapeutics Co.Ltd (3) · Cancer Institute and Hospital, Chinese Academy of Medical Sciences (1) · The First Hospital of Jilin University (1)
Often tested with
Tested in the same studies.
Izalontamab brengitecan (1) · CVL006 (1) · MT027 (1) · QH101 (1) · META10 (1) · TAEST1901 (1) · TCN 201 (1) · Base Edited Natural Killer Cells NK510 (1)
Studies
Open first, then newest update. How each study uses KXV01 is read from its arms, and is right about nine times in ten.
Testing it · 5
- KXV01 Injection in Patients With Advanced Solid Tumor (Including Osteosarcoma and Sarcoma)RecruitingPhase 1TCRx Therapeutics Co.LtdNCT07596693Written as KXV01 TCR Lentinvivo Injection
- Rare Tumor Focused Platform Study of Innovative Therapies and Technologies (PLATFORM2)Not yet recruitingPhase 1/2Cancer Institute and Hospital, Chinese Academy of Medical SciencesNCT07307053Written as KXV01 TCR Lentinvivo Injection
- Personalized KXV01 Lentinvivo (TCR) Injection as the Therapy for Advanced Solid TumorsNot yet recruitingPhase 1TCRx Therapeutics Co.LtdNCT07275853Written as KXV01 TCR Lentinvivo Injection
- Personalized KXV01 TCR Lentinvivo Injection as the Therapy for Advanced Solid TumorsNot yet recruitingPhase 1The First Hospital of Jilin UniversityNCT07207681Written as KXV01 TCR Lentinvivo Injection
- Personalized KXV01 TCR Lentinvivo Injection as the Therapy for Advanced Solid TumorsNot yet recruitingPhase 1TCRx Therapeutics Co.LtdNCT07196579Written as KXV01 TCR Lentinvivo Injection